NCT01964378 2021-07-15
CORAL
Tris Pharma, Inc.
Phase 3 Terminated
Clinical Trials
10 trialsNCT00981578 2020-03-11
ExAblate Conformal Bone System Treatment of Metastatic Bone Tumors for the Palliation of Pain
InSightec
Phase NA Terminated
NCT00352664 2016-05-09
The Effect of Donepezil on Sedation and Other Symptoms
M.D. Anderson Cancer Center
Phase 3 Terminated
NCT00634010 2016-05-09
Morphine Versus Methadone As First Line Strong Opioid for Cancer Pain
M.D. Anderson Cancer Center
Phase 3 Terminated
NCT01931865 2015-12-31
IncobotulinumtoxinA for Treatment of Focal Cancer Pain After Surgery and/or Radiation
Yale University
Phase 2 Terminated
NCT01384292 2015-06-01
Assessment of Efficacy and Safety in Relieving Opioid-induced Constipation in Patients With Cancer-related Pain
AstraZeneca
Phase 3 Terminated
NCT01350583 2013-08-14
Bicarbonate for Tumor Related Pain
H. Lee Moffitt Cancer Center and Research Institute
Phase NA Terminated
NCT00803283 2013-08-12
A Study to Compare Safety and Efficacy of Osmotic Release Oral Syytem (OROS) Hydromorphone Hydrochloride (HCl) With Morphine Sustain Release (SR) in Participants With Cancer Pain
Johnson & Johnson Taiwan Ltd
Phase 3 Terminated
NCT00684242 2013-01-28
Lenalidomide (Revlimid) for the Treatment of Refractory Cancer Pain
M.D. Anderson Cancer Center
Phase 2 Terminated
NCT00842829 2012-10-01
Study of Breakthrough Cancer Pain: Assessment of Fentanyl Buccal Tablets Titration and Treatment in Opioid-Tolerant Patients
Teva Branded Pharmaceutical Products R&D, Inc.
Phase 4 Terminated